Top Houston, TX Pharmaceutical Startups (22)
ReviveRX is a leading licensed mail-order pharmacy specializing in generic and compounded medications. Our compounds are expertly crafted in USP-certified clean rooms at our Houston headquarters, ensuring the highest quality standards. We work closely with best-in-class pharmacists, scientists, healthcare providers, and pharmaceutical manufacturers to provide high-quality, dependable products to our patients and clinic partners.
ARTIDIS AG is a clinical-stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. By combining its proprietary nanotechnology platform for rapid tissue analysis with a holistic data solution, ARTIDIS accelerates drug discovery, tissue engineering, and personalized treatment. The company focuses its research and development efforts on solid tumors to enhance responses to...
Clinical stage pharmaceutical company developing topical, non-narcotic medications to treat pain.
Nano3D Biosciences develops products for in vitro cell culturing applications.
ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.
CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.
Medical Research Consultants (MRC) specializes in Record Retrieval & Management, Nurse Audits & Analysis, and Regulatory Compliance services to Legal, Pharmaceutical, Healthcare & Corporate entities. MRC’s diverse solutions are backed with more than two decades of expertise, and customized to our clients’ business goals. As a nationally certified Women's Business Enterprise and employee-owned business, MRC is committed to leveraging the...
RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory...
Memgen is developing viral immunotherapies to harness the power of the immune system to cure cancer and protect people from COVID-19
Pulmotect develops products that boost the innate immune system to protect against a wide range of lung infections.
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options. Salarius’ product portfolio includes seclidemstat, a reversible LSD1 inhibitor, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule targeted protein degrader. Seclidemstat is currently in...
Award-winning clinical research organization (CRO) that delivers high-quality clinical trials through strong relationships with specialization in oncology, neurology and rare diseases.
We are located near the Texas Medical Center in Houston, Texas. Under the leadership of Alice S. Weissfeld, Ph.D., D (ABMM), and Paula H. Vance, SM(NRM), SM(ASCP), CLS(M), msi has remained in the forefront of microbiology testing since 1984 and maintains a reputation for scientifically reliable testing. Originally founded as a clinical microbiology reference laboratory, msi subsequently expanded its services...
Vivione is a TSX Venture Exchange listed biosciences company focused on the commercialization of its proprietary RAPID-B system.
